Design of experiments; Dry powder inhalers; Liposome; Spray-drying
Abstract :
[en] Liposomes are promising carriers for pulmonary drug delivery due to their biocompatibility and controlled-release properties. However, their stability in aqueous suspension is limited, leading to aggregation and reduced therapeutic efficiency. Converting liposomal dispersions into dry powders for inhalation (DPIs) is a potential strategy to overcome these limitations. Spray-drying (SD) is particularly attractive for this purpose, offering precise control over particle properties along with speed, cost-efficiency, and scalability. Yet, the thermal and mechanical stresses involved in this process and their effects on liposomal integrity remain poorly understood, limiting its broader application. In this study, we developed a systematic framework integrating Design of Experiments (DOE) with scale-up-oriented processing, combining supercritical fluid technology (PGSS) for liposome formation with subsequent spray-drying of high solid content suspensions. Two complementary DoE approaches were applied: DOEA optimized drying parameters and carbohydrate type, testing trehalose and hydroxypropyl-β-cyclodextrin (HPβCD), while DOEB assessed the effects of active pharmaceutical ingredients (APIs) hydrophobicity, lipid composition (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000 (DSPE-PEG2000) percentage), and carbohydrate-to-liposome ratio. Optimized spray-dried powders exhibited preserved liposome structure (mean diameter < 200 nm, narrow polydispersity index (PdI), near-neutral zeta potential (ZP)), favorable aerodynamic properties (∼3 µm, extra-fine particle fraction (eFPF) > 20% and fine particle fraction (FPF) > 60%), low residual moisture (<5%), and high drying yields (>75%). Mechanistic insights revealed that HPβCD significantly protects liposomes during atomization, while drug retention was governed by PEGylated lipid content, lipid-to-carbohydrate ratio, and API hydrophobicity. Co-encapsulation of clinically relevant drug combinations (formoterol/budesonide and ciclesonide/indacaterol) produced uniform powders with efficient aerosolization, highlighting the therapeutic potential of these formulations. Collectively, these results establish a robust, scalable, and reproducible approach for designing liposomal DPIs, balancing formulation composition, excipient selection, and process parameters. This study demonstrates that strategic integration of scalable technologies can reconcile structural stability, aerodynamic performance, and manufacturability, paving the way for the industrial translation of liposomal dry powders for targeted pulmonary therapies, including asthma and chronic obstructive pulmonary disease (COPD).
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Bya, Laure-Anne ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Dinh, Tuan Nghia ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Penoy, Noémie ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Sacre, Pierre-Yves ; Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Cataldo, Didier ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et pathologiques
Hendrickx, Erika; Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles (ULB), B-6041 Gosselies, Belgium
Conrard, Louise; Center for Microscopy and Molecular Imaging (CMMI), Université Libre de Bruxelles (ULB), B-6041 Gosselies, Belgium
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Piel, Géraldine ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Lechanteur, Anna ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Language :
English
Title :
Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design.
Alternative titles :
[fr] Optimisation des liposomes séchés par atomisation pour l’administration pulmonaire : impact de la composition lipidique et des paramètres de séchage à l’aide d’un plan d’expériences.
Original title :
[en] Optimizing spray-dried liposomes for pulmonary delivery: impact of lipids composition and of drying parameters using experimental design.
Publication date :
25 February 2026
Journal title :
European Journal of Pharmaceutics and Biopharmaceutics
Bashyal, S., Suwal, N., Thapa, R., Bagale, L. R., Sugandhi, V. V., Subedi, S., Idrees, S., Panth, N., Elwakil, B. H., El-Khatib, M., Dua, K., & Paudel, K. R. (2025). Liposomal drug delivery system for lung diseases: Recent advancement and future perspectives. In Nanomedicine: Nanotechnology, Biology, and Medicine (Vol. 69). Elsevier Inc. Doi: 10.1016/j.nano.2025.102855
Pasero, L., Susa, F., Limongi, T., & Pisano, R. (2024). A Review on Micro and Nanoengineering in Powder-Based Pulmonary Drug Delivery. In International Journal of Pharmaceutics (Vol. 659). Elsevier B.V. Doi: 10.1016/j.ijpharm.2024.124248.
Senjab, R. M., AlSawaftah, N., Abuwatfa, W. H., & Husseini, G. A. (2024). Advances in liposomal nanotechnology: from concept to clinics. RSC Pharmaceutics, 1(5), 928–948. Doi: 10.1039/D4PM00176A
Zhang, J., Huang, Y., Shen, W., Zeng, Y., Miao, Y., Feng, N., & Ci, T. (2025). Effects of Surface Charge of Inhaled Liposomes on Drug Efficacy and Biocompatibility. Pharmaceutics, 17(3). Doi: 10.3390/pharmaceutics17030329
Lin, K. C., Lin, H. Y., Yang, C. Y., Chu, Y. L., Xie, R. H., Wang, C. M., Tseng, Y. L., Chen, H., Chung, J. H. Y., Yang, J. W., & Chen, G. Y. (2025). Inhalable Mucociliary-On-Chip System Revealing Pulmonary Clearance Dynamics in Nanodrug Delivery. ACS Nano, 19(2), 2228–2244. Doi: 10.1021/acsnano.4c11693
X. Yan, X. Sha, Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa, in: Pharmaceutics (Vol. 15, Number 10), Multidisciplinary Digital Publishing Institute (MDPI), 2023, Doi: 10.3390/pharmaceutics15102457.
D. Cipolla, I. Gonda, H.K. Chan, Liposomal formulations for inhalation, in Therapeutic Delivery, Vol. 4, Number 8, pp. 1047–1072, Newlands Press Ltd., 2013, Doi: 10.4155/tde.13.71.
X. Xu, F. Tian, Y. Pan, T. Zhang, L. Deng, H. Jiang, J. Han, J. Liu, Y. Zhao, W. Liu, Emerging mechanistic insights into liposomal stability: Full process management from production and storage to food application, Chemical Engineering Journal, Vol. 505, Elsevier B.V., 2025, Doi: 10.1016/j.cej.2025.159552.
Yu, J. Y., Chuesiang, P., Shin, G. H., & Park, H. J. (2021). Post-processing techniques for the improvement of liposome stability. Pharmaceutics, 13(7). Doi: 10.3390/pharmaceutics13071023
Rudokas, M., Najlah, M., Alhnan, M. A., & Elhissi, A. (2016). Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications. Medical Principles and Practice, 25(2), 60–72. Doi: 10.1159/000445116
Shahin, H. I., & Chablani, L. (2023). A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications. In Journal of Drug Delivery Science and Technology (Vol. 84). Editions de Sante. Doi: 10.1016/j.jddst.2023.104553.
B. Chaurasiya, Y.Y. Zhao, Dry powder for pulmonary delivery: a comprehensive review, In Pharmaceutics, Vol. 13, Number 1, pp. 1–28, MDPI AG, 2021, Doi: 10.3390/pharmaceutics13010031.
A. Negi, S. Nimbkar, J.A. Moses, Engineering inhalable therapeutic particles: conventional and emerging approaches, in Pharmaceutics (Vol. 15, Number 12). Multidisciplinary Digital Publishing Institute (MDPI), 2023, Doi: 10.3390/pharmaceutics15122706.
Scherließ, R., Bock, S., Bungert, N., Neustock, A., & Valentin, L. (2022). Particle engineering in dry powders for inhalation. Eur J Pharm Sci, 172. Doi: 10.1016/j.ejps.2022.106158
Spahn, J. E., Zhang, F., & Smyth, H. D. C. (2022). Mixing of dry powders for inhalation: A review. In International Journal of Pharmaceutics (Vol. 619). Elsevier B.V. Doi: 10.1016/j.ijpharm.2022.121736.
N. Alhajj, N.J. O’Reilly, H. Cathcart, Designing enhanced spray dried particles for inhalation: A review of the impact of excipients and processing parameters on particle properties, In Powder Technology (Vol. 384, pp. 313–331), 2021, Elsevier B.V. Doi: 10.1016/j.powtec.2021.02.031.
Lechanteur, A., & Evrard, B. (2020). Influence of composition and spray-drying process parameters on carrier-free DPI properties and behaviors in the lung: A review. Pharmaceutics, 12(1). Doi: 10.3390/pharmaceutics12010055
Vishali, D. A., Monisha, J., Sivakamasundari, S. K., Moses, J. A., & Anandharamakrishnan, C. (2019). Spray freeze drying: Emerging applications in drug delivery. In Journal of Controlled Release (Vol. 300, pp. 93–101). Elsevier B.V. Doi: 10.1016/j.jconrel.2019.02.044.
A. Ziaee, A.B. Albadarin, L. Padrela, T. Femmer, E. O’Reilly, G. Walker, Spray drying of pharmaceuticals and biopharmaceuticals: critical parameters and experimental process optimization approaches, in: Eur. J. Pharm. Sci., 2019, 127, pp. 300–318, Elsevier B.V. Doi: 10.1016/j.ejps.2018.10.026.
Furst, T., Dakwar, G. R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., & Piel, G. (2016). Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA. Journal of Controlled Release, 236, 68–78. Doi: 10.1016/j.jconrel.2016.06.028
Kaialy, W., & Nokhodchi, A. (2013). Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler. Pharmaceutical Research, 30(2), 458–477. Doi: 10.1007/s11095-012-0892-4
Nugraheni, R. W., Setyawan, D., & Yusuf, H. (2017). Physical characteristics of liposomal formulation dispersed in HPMC matrix and freeze-dried using maltodextrin and mannitol as lyoprotectant. Pharmaceutical Sciences, 24(4), 285–292. Doi: 10.15171/PS.2017.42
Dattani, S., Li, X., Lampa, C., Barriscale, A., Damadzadeh, B., Lechuga-Ballesteros, D., & Jasti, B. R. (2025). Development of Spray-Dried Micelles, Liposomes, and Solid Lipid Nanoparticles for Enhanced Stability. Pharmaceutics, 17(1). Doi: 10.3390/pharmaceutics17010122
Safaeian Laein, S., Samborska, K., Can Karaca, A., Mostashari, P., Akbarbaglu, Z., Sarabandi, K., & Jafari, S. M. (2024). Strategies for further stabilization of lipid-based delivery systems with a focus on solidification by spray-drying. Trends in Food Science & Technology, 146, 104412. Doi: 10.1016/j.tifs.2024.104412
P. Goldbach, H. Brochart, A. Stamm, Spray-drying of liposomes for a pulmonary administration, I. Chemical stability of phospholipids, In Drug Development and Industrial Pharmacy, 1993, Vol. 19, Number 19.
Wessman, P., Edwards, K., & Mahlin, D. (2010). Structural effects caused by spray- and freeze-drying of liposomes and bilayer disks. Journal of Pharmaceutical Sciences, 99(4), 2032–2048. Doi: 10.1002/jps.21972
Van Den Hoven, J. M., Metselaar, J. M., Storm, G., Beijnen, J. H., & Nuijen, B. (2012). Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes. International Journal of Pharmaceutics, 438(1–2), 209–216. Doi: 10.1016/j.ijpharm.2012.08.046
Khan, I., Edes, K., Alsaadi, I., Al-Khaial, M. Q., Bnyan, R., Khan, S. A., Sadozai, S. K., Khan, W., & Yousaf, S. (2024). Investigation of Spray Drying Parameters to Formulate Novel Spray-Dried Proliposome Powder Formulations Followed by Their Aerosolization Performance. Pharmaceutics, 16(12). Doi: 10.3390/pharmaceutics16121541
Meenach, S. A., Anderson, K. W., Zach Hilt, J., McGarry, R. C., & Mansour, H. M. (2013). Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. European Journal of Pharmaceutical Sciences, 49(4), 699–711. Doi: 10.1016/j.ejps.2013.05.012
Ingvarsson, P. T., Yang, M., Nielsen, H. Mø., Rantanen, J., & Foged, C. (2011). Stabilization of liposomes during drying. In Expert Opinion on Drug Delivery (Vol. 8, Number 3, pp. 375–388). Doi: 10.1517/17425247.2011.553219
Delma, K. L., Penoy, N., Sakira, A. K., Egrek, S., Sacheli, R., Grignard, B., Hayette, M. P., Issa Somé, T., Evrard, B., Semdé, R., & Piel, G. (2023). Use of supercritical CO2 for the sterilization of liposomes: Study of the influence of sterilization conditions on the chemical and physical stability of phospholipids and liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 183, 112–118. Doi: 10.1016/j.ejpb.2023.01.002
Penoy, N., Delma, K. L., Tonakpon, H. A., Grignard, B., Evrard, B., & Piel, G. (2022). An innovative one step green supercritical CO2 process for the production of liposomes co-encapsulating both a hydrophobic and a hydrophilic compound for pulmonary administration. International Journal of Pharmaceutics, 627. Doi: 10.1016/j.ijpharm.2022.122212
Abadelah, M., Chrystyn, H., Bagherisadeghi, G., Abdalla, G., & Larhrib, H. (2018). Study of the Emitted Dose After Two Separate Inhalations at Different Inhalation Flow Rates and Volumes and an Assessment of Aerodynamic Characteristics of Indacaterol Onbrez Breezhaler® 150 and 300μg. AAPS PharmSciTech, 19(1), 251–261. Doi: 10.1208/s12249-017-0841-y
R.W. Dal Negro, Dry powder inhalers and the right things to remember: a concept review, in: Multidisciplinary Respiratory Medicine (Vol. 10, Number 1). BioMed Central Ltd., 2015, Doi: 10.1186/s40248-015-0012-5.
Lechanteur, A., Plougonven, E., Orozco, L., Lumay, G., Vandewalle, N., Léonard, A., & Evrard, B. (2022). Engineered-inhaled particles: Influence of carbohydrates excipients nature on powder properties and behavior. International Journal of Pharmaceutics, 613. Doi: 10.1016/j.ijpharm.2021.121319
Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications. In Advanced Drug Delivery Reviews (Vol. 65, Number 1, pp. 36–48). Doi: 10.1016/j.addr.2012.09.037
J.O. Eloy, M. Claro de Souza, R. Petrilli, J.P.A. Barcellos, R.J. Lee, J.M. Marchetti, Liposomes as carriers of hydrophilic small molecule drugs: Strategies to enhance encapsulation and delivery, in Colloids and Surfaces B: Biointerfaces, 123, Elsevier, 2014, pp. 345–363, Doi: 10.1016/j.colsurfb.2014.09.029.
Penoy, N., Grignard, B., Evrard, B., & Piel, G. (2021). A supercritical fluid technology for liposome production and comparison with the film hydration method. International Journal of Pharmaceutics, 592. Doi: 10.1016/j.ijpharm.2020.120093
Abbassi, M., Nejad Ebrahimi, S., & Rahimi, M. (2025). Optimized spray-drying of zinc sulfate-loaded liposomes: physicochemical characterization and in vitro release assessment. Scientific Reports, 15(1). Doi: 10.1038/s41598-025-05948-4
Lutta, A., Knopp, M. M., Tollemeto, M., Pedersen, G. K., Schmidt, S. T., Grohganz, H., & Hagner Nielsen, L. (2024). The interplay between trehalose and dextran as spray drying precursors for cationic liposomes. International Journal of Pharmaceutics, 652. Doi: 10.1016/j.ijpharm.2024.123798
Susa, F., Bucca, G., Limongi, T., Cauda, V., & Pisano, R. (2021). Enhancing the preservation of liposomes: The role of cryoprotectants, lipid formulations and freezing approaches. Cryobiology, 98, 46–56. Doi: 10.1016/j.cryobiol.2020.12.009
Dufour, G., Bigazzi, W., Wong, N., Boschini, F., De Tullio, P., Piel, G., Cataldo, D., & Evrard, B. (2015). Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide. International Journal of Pharmaceutics, 495(2), 869–878. Doi: 10.1016/j.ijpharm.2015.09.052
Lechanteur, A., Gresse, E., Orozco, L., Plougonven, E., Léonard, A., Vandewalle, N., Lumay, G., & Evrard, B. (2023). Inhalation powder development without carrier: How to engineer ultra-flying microparticles? Eur J Pharm Biopharm, 191, 26–35. Doi: 10.1016/j.ejpb.2023.08.010
Evrard, B., Bertholet, P., Gueders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J. M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96(3), 403–410. Doi: 10.1016/j.jconrel.2004.02.010
Iskandar, A. R., Kolli, A. R., Giralt, A., Neau, L., Fatarova, M., Kondylis, A., Torres, L. O., Majeed, S., Merg, C., Corciulo, M., Trivedi, K., Guedj, E., Frentzel, S., Calvino, F., Guy, P. A., Ivanov, N. V., Peitsch, M. C., & Hoeng, J. (2021). Assessment of in vitro kinetics and biological impact of nebulized trehalose on human bronchial epithelium. Food and Chemical Toxicology, 157. Doi: 10.1016/j.fct.2021.112577
D. Zillen, M. Beugeling, W.L.J. Hinrichs, H.W. Frijlink, F. Grasmeijer, Natural and bioinspired excipients for dry powder inhalation formulations, in: Current Opinion in Colloid and Interface Science, Vol. 56, Elsevier Ltd., 2021, Doi: 10.1016/j.cocis.2021.101497.
Ong, S. G. M., Chitneni, M., Lee, K. S., Ming, L. C., & Yuen, K. H. (2016). Evaluation of extrusion technique for nanosizing liposomes. Pharmaceutics, 8(4). Doi: 10.3390/pharmaceutics8040036
Ota, A., Mochizuki, A., Sou, K., & Takeoka, S. (2023). Evaluation of a static mixer as a new microfluidic method for liposome formulation. Frontiers in Bioengineering and Biotechnology, 11. Doi: 10.3389/fbioe.2023.1229829
Steiner, D., Schumann, L. V., & Bunjes, H. (2022). Processing of Lipid Nanodispersions into Solid Powders by Spray Drying. Pharmaceutics, 14(11). Doi: 10.3390/pharmaceutics14112464
Zimmermann, C. M., Baldassi, D., Chan, K., Adams, N. B. P., Neumann, A., Porras-Gonzalez, D. L., Wei, X., Kneidinger, N., Stoleriu, M. G., Burgstaller, G., Witzigmann, D., Luciani, P., & Merkel, O. M. (2022). Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery. Journal of Controlled Release, 351, 137–150. Doi: 10.1016/j.jconrel.2022.09.021
Poozesh, S., Connaughton, P., Sides, S., Lechuga-Ballesteros, D., Patel, S. M., & Manikwar, P. (2025). Spray drying process challenges and considerations for inhaled biologics. In Journal of Pharmaceutical Sciences (Vol. 114, Number 2, pp. 766–781). Elsevier B.V. Doi: 10.1016/j.xphs.2024.11.028.
Grasmeijer, N., Stankovic, M., De Waard, H., Frijlink, H. W., & Hinrichs, W. L. J. (2013). Unraveling protein stabilization mechanisms: Vitrification and water replacement in a glass transition temperature controlled system. Biochimica et Biophysica Acta - Proteins and Proteomics, 1834(4), 763–769. Doi: 10.1016/j.bbapap.2013.01.020
Roe, K. D., & Labuza, T. P. (2005). Glass transition and crystallization of amorphous trehalose-sucrose mixtures. International Journal of Food Properties, 8(3), 559–574. Doi: 10.1080/10942910500269824
Wilhelms, B., Broscheit, J., & Shityakov, S. (2023). Chemical Analysis and Molecular Modelling of Cyclodextrin-Formulated Propofol and Its Sodium Salt to Improve Drug Solubility, Stability and Pharmacokinetics (Cytogenotoxicity). Pharmaceuticals, 16(5). Doi: 10.3390/ph16050667
Zheng, Y., & Chow, A. H. L. (2009). Production and characterization of a spray-dried hydroxypropyl-β- cyclodextrinquercetin complex Spray-dried hydroxypropyl-β-cyclodextrin/ quercetin complex. Drug Development and Industrial Pharmacy, 35(6), 727–734. Doi: 10.1080/03639040802526805
Z. Hammoud, N. Khreich, L. Auezova, S. Fourmentin, A. Elaissari, H. Greige-Gerges, Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance, in International Journal of Pharmaceutics, 2019, Vol. 564, pp. 59–76, Elsevier B.V. Doi: 10.1016/j.ijpharm.2019.03.063.
Kumar, A., Cincotti, A., & Aparicio, S. (2020). A theoretical study on trehalose + water mixtures for dry preservation purposes. Molecules, 25(6). Doi: 10.3390/molecules25061435
Yergey, A. L., Blank, P. S., Cologna, S. M., Backlund, P. S., Porter, F. D., & Darling, A. J. (2017). Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1. PLoS ONE, 12(4). Doi: 10.1371/journal.pone.0175478
M. Danaei, M. Dehghankhold, S. Ataei, F. Hasanzadeh Davarani, R. Javanmard, A. Dokhani, S. Khorasani, M.R. Mozafari, Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems, in Pharmaceutics (Vol. 10, Number 2). MDPI AG. Doi: 10.3390/pharmaceutics10020057, 2018.
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (2016). PEGylation of lipoplexes: The right balance between cytotoxicity and siRNA effectiveness. European Journal of Pharmaceutical Sciences, 93, 493–503. Doi: 10.1016/j.ejps.2016.08.058
Zhao, J., Qin, L., Song, R., Su, J., Yuan, Y., Zhang, X., & Mao, S. (2022). Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung. European Journal of Pharmaceutics and Biopharmaceutics, 172, 101–111. Doi: 10.1016/j.ejpb.2022.01.009
LaForce, C., Albers, F., Danilewicz, A., Jeynes-Ellis, A., Kraft, M., Panettieri, R. A., Rees, R., Bardsley, S., Dunsire, L., Harrison, T., Sobande, O., Surujbally, R., Trudo, F., Cappelletti, C., Papi, A., Beasley, R., Chipps, B. E., Israel, E., Pandya, H., … Bacharier, L. B. (2025). As-Needed Albuterol–Budesonide in Mild Asthma. New England Journal of Medicine, 393(2), 113–124. Doi: 10.1056/nejmoa2504544
Bai, S., & Ahsan, F. (2010). Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboembolism. Journal of Pharmaceutical Sciences, 99(11), 4554–4564. Doi: 10.1002/jps.22160
P. Muralidharan, E. Mallory, M. Malapit, H. Don, H.M. Mansour, Inhalable PEGylated phospholipid nanocarriers and PEGylated therapeutics for respiratory delivery as aerosolized colloidal dispersions and dry powder inhalers, Pharmaceutics 6(2) (2014) 333–353, MDPI AG, Doi: 10.3390/pharmaceutics6020333.
Giakoumatos, E. C., Gascoigne, L., Gumí-Audenis, B., García, Á. G., Tuinier, R., & Voets, I. K. (2022). Impact of poly(ethylene glycol) functionalized lipids on ordering and fluidity of colloid supported lipid bilayers. Soft Matter, 18(39), 7569–7578. Doi: 10.1039/d2sm00806h
Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., & Deng, Y. (2015). A review on phospholipids and their main applications in drug delivery systems. In Asian Journal of Pharmaceutical Sciences (Vol. 10, Number 2, pp. 81–98). Shenyang Pharmaceutical University. Doi: 10.1016/j.ajps.2014.09.004.
Tunsirikongkon, A., Pyo, Y. C., Kim, D. H., Lee, S. E., & Park, J. S. (2019). Optimization of polyarginine-conjugated PEG lipid grafted proliposome formulation for enhanced cellular association of a protein drug. Pharmaceutics, 11(6). Doi: 10.3390/pharmaceutics11060272
Li, J., Zheng, H., Xu, E. Y., Moehwald, M., Chen, L., Zhang, X., & Mao, S. (2021). Inhalable PLGA microspheres: Tunable lung retention and systemic exposure via polyethylene glycol modification. Acta Biomaterialia, 123, 325–334. Doi: 10.1016/j.actbio.2020.12.061
Osman, G., Rodriguez, J., Chan, S. Y., Chisholm, J., Duncan, G., Kim, N., Tatler, A. L., Shakesheff, K. M., Hanes, J., Suk, J. S., & Dixon, J. E. (2018). PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy. Journal of Controlled Release, 285, 35–45. Doi: 10.1016/j.jconrel.2018.07.001
Changsan, N., Chan, H. K., Separovic, F., & Srichana, T. (2009). Physicochemical characterization and stability of rifampicin liposome dry powder formulations for inhalation. Journal of Pharmaceutical Sciences, 98(2), 628–639. Doi: 10.1002/jps.21441
Kujawski, J., Bernard, M. K., Janusz, A., & Kuźma, W. (2012). Prediction of log P: ALOGPS application in medicinal chemistry education. Journal of Chemical Education, 89(1), 64–67. Doi: 10.1021/ed100444h
Bya, L. A., Bottero, B., Coeurderoi, A., Dinh, T. N., Sacré, P. Y., Ziemons, E., Cataldo, D., Piel, G., Evrard, B., & Lechanteur, A. (2025). Formulation of a dry powder for inhalation combining ciclesonide and indacaterol maleate using spray drying. International Journal of Pharmaceutics, 678. Doi: 10.1016/j.ijpharm.2025.125696
Piñol-Cancer, M., Fernández-Méndez, L., Carrillo-Romero, J., Urkola-Arsuaga, A., Azkargorta, M., Elortza, F., Goñi-de-Cerio, F., García-Mouton, C., de Alejo, C. M. P., Ismalaj, E., Cañadas, O., Pérez-Gil, J., Ruíz-Cabello, J., & Carregal-Romero, S. (2025). The role of PEGylation in the pulmonary delivery of antifibrotic liposomal therapies. Journal of Controlled Release, 386. Doi: 10.1016/j.jconrel.2025.114134
Chen, K. H., Mueannoom, W., Gaisford, S., & Kett, V. L. (2012). Investigation into the effect of varying l -leucine concentration on the product characteristics of spray-dried liposome powders. Journal of Pharmacy and Pharmacology, 64(10), 1412–1424. Doi: 10.1111/j.2042-7158.2012.01521.x
Altin, G., Gültekin-Özgüven, M., & Ozcelik, B. (2018). Chitosan coated liposome dispersions loaded with cacao hull waste extract: Effect of spray drying on physico-chemical stability and in vitro bioaccessibility. Journal of Food Engineering, 223, 91–98. Doi: 10.1016/j.jfoodeng.2017.12.005
Sarabandi, K., & Jafari, S. M. (2020). Effect of chitosan coating on the properties of nanoliposomes loaded with flaxseed-peptide fractions: Stability during spray-drying. Food Chemistry, 310. Doi: 10.1016/j.foodchem.2019.125951
Anderson, M., & Omri, A. (2004). The Effect of Different Lipid Components on the in Vitro Stability and Release Kinetics of Liposome Formulations. Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, 11(1), 33–39. Doi: 10.1080/10717540490265243
Charnvanich, D., Vardhanabhuti, N., & Kulvanich, P. (2010). Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders. AAPS PharmSciTech, 11(2), 832–842. Doi: 10.1208/s12249-010-9442-8
Willis, L., Hayes, D., & Mansour, H. M. (2012). Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery. In Lung (Vol. 190, Number 3, pp. 251–262). Doi: 10.1007/s00408-011-9360-x
Marianni, B., Polonini, H., & Oliveira, M. A. L. (2021). Ensuring homogeneity in powder mixtures for pharmaceuticals and dietary supplements: Evaluation of a 3-axis mixing equipment. Pharmaceutics, 13(4). Doi: 10.3390/pharmaceutics13040563
Nguyen, D., Rasmuson, A., Björn, I. N., & Thalberg, K. (2015). Mechanistic time scales in adhesive mixing investigated by dry particle sizing. Eur J Pharm Biopharm, 69, 19–25. Doi: 10.1016/j.ejps.2014.12.016
Ou, C., Hang, J., & Deng, Q. (2020). Particle deposition in human lung airways: Effects of airflow, particle size, and mechanisms. Aerosol and Air Quality Research, 20(12), 2846–2858. Doi: 10.4209/aaqr.2020.02.0067
Magramane, S., Vlahović, K., Gordon, P., Kállai-Szabó, N., Zelkó, R., Antal, I., & Farkas, D. (2023). Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements. In Pharmaceuticals (Vol. 16, Number 12). Multidisciplinary Digital Publishing Institute (MDPI). Doi: 10.3390/ph16121658.
M.D. Louey, M. Van Oort, A.J. Hickey, Aerosol Dispersion of Respirable Particles in Narrow Size Distributions Using Drug-Alone and Lactose-Blend Formulations, 2004.
Mitchell, J. P., Nagel, M. W., Wiersema, K. J., & Doyle, C. C. (2003). Aerodynamic Particle Size Analysis of Aerosols from Pressurized Metered-Dose Inhalers: Comparison of Andersen 8-Stage Cascade Impactor, Next Generation Pharmaceutical Impactor, and Model 3321 Aerodynamic Par-ticle Sizer Aerosol Spectrometer. In AAPS PharmSciTech (Vol. 4, Number 4). http://www.aapspharmscitech.org
Behara, S. R. B., Longest, P. W., Farkas, D. R., & Hindle, M. (2014). Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations. Journal of Pharmaceutical Sciences, 103(2), 465–477. Doi: 10.1002/jps.23775
Braido, F., Scichilone, N., Lavorini, F., Usmani, O. S., Dubuske, L., Boulet, L. P., Mosges, R., Nunes, C., Sanchez-Borges, M., Ansotegui, I. J., Ebisawa, M., Levi-Schaffer, F., Rosenwasser, L. J., Bousquet, J., Zuberbier, T., Canonica, G. W., Cruz, A., Yanez, A., Yorgancioglu, A., … Zhang, L. (2016). Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN). World Allergy Organization Journal, 9(1), 1–6. Doi: 10.1186/s40413-016-0123-2
Usmani, O. S., & Barnes, P. J. (2012). Assessing and treating small airways disease in asthma and chronic obstructive pulmonary disease. Annals of Medicine, 44(2), 146–156. Doi: 10.3109/07853890.2011.585656
Hillyer, E. V., Price, D. B., Chrystyn, H., Martin, R. J., Israel, E., van Aalderen, W. M. C., Papi, A., Usmani, O. S., & Roche, N. (2018). Harmonizing the Nomenclature for Therapeutic Aerosol Particle Size: A Proposal. In Journal of aerosol medicine and pulmonary drug delivery (Vol. 31, Number 2, pp. 111–113). NLM (Medline). Doi: 10.1089/jamp.2017.1396.
Usmani, O. S., Scichilone, N., Mignot, B., Belmans, D., Van Holsbeke, C., De Backer, J., De Maria, R., Cuoghi, E., Topole, E., & Georges, G. (2020). Airway deposition of extrafine inhaled triple therapy in patients with copd: A model approach based on functional respiratory imaging computer simulations. International Journal of COPD, 15, 2433–2440. Doi: 10.2147/COPD.S269001
Tse, J. Y., Kadota, K., Imakubo, T., Uchiyama, H., & Tozuka, Y. (2021). Enhancement of the extra-fine particle fraction of levofloxacin embedded in excipient matrix formulations for dry powder inhaler using response surface methodology. European Journal of Pharmaceutical Sciences, 156. Doi: 10.1016/j.ejps.2020.105600
Almurshedi, A. S., Aljunaidel, H. A., Alquadeib, B., Aldosari, B. N., Alfagih, I. M., Almarshidy, S. S., Eltahir, E. K. D., & Mohamoud, A. Z. (2021). Development of inhalable nanostructured lipid carriers for ciprofloxacin for noncystic fibrosis bronchiectasis treatment. International Journal of Nanomedicine, 16, 2405–2417. Doi: 10.2147/IJN.S286896
Gresse, E., Rousseau, J., Akdim, M., du Bois, A., Lechanteur, A., & Evrard, B. (2024). Enhancement of inhaled micronized powder flow properties for accurate capsules filling. Powder Technology, 437, 119576. Doi: 10.1016/j.powtec.2024.119576
Santos Gomes, B. F., Bya, L. A., Koch, N., Cabral-Marques, H., Evrard, B., & Lechanteur, A. (2025). Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder. The AAPS Journal, 27(1), 30. Doi: 10.1208/s12248-025-01015-y
R.Y.K. Chang, P.C.L. Kwok, D. Khanal, S. Morales, E. Kutter, J. Li, H.K. Chan, Inhalable bacteriophage powders: glass transition temperature and bioactivity stabilization, Bioeng. Translational Med. 5 (2) (2020), doi: 10.1002/btm2.10159
C. Haeuser, P. Goldbach, J. Huwyler, W. Friess, A. Allmendinger, Be aggressive! amorphous excipients enabling single-step freeze-drying of monoclonal antibody formulations, Pharmaceutics 11 (11) (2019), doi: 10.3390/pharmaceutics11110616
S. Milani, H. Faghihi, A. Roulholamini, M. Amini, H. Montazeri, A. Vatanara, Hydroxypropyl beta cyclodextrin: a water-replacement agent or a surfactant upon spray freeze-drying of IgG with enhanced stability and aerosolization, Drug Dev. Ind. Pharm. 46 (3) (2020) 403–411, doi: 10.1080/03639045.2020.1724131
